Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title | Funding Agency | Discipline | Who's Eligible |
Award Amount |
Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 3/18/2020 | Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 12/06/2021 | Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 2/16/2021 | Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 6/16/2021 | Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 10/01/2021 | Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $100,000 | 4/18/2022 |
| Deadline: 6/08/2020 | Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 7/28/2020 | Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 7/09/2021 | Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/16/2021 | Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 1/07/2022 | Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/05/2020 | Juvenile Protective Factors and Their Effects on Aging (R01, R03) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 4/05/2021 | Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42, R43/R44) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 6/05/2021 | Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01, R21) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/16/2021 | Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/05/2020 | Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/21/2021 | HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 10/05/2021 | Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 3/14/2022 | Limited Competition: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Coordinating Center (U24 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 7/15/2021 | Clinical and Translational Science Award (U54 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 11/09/2021 | Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
